Saturday, November 2, 2024
Home Tags Health-007-November-2018

Health-007-November-2018 Related News

Dementia in Europe: a public health priority?

Dementia in Europe: a public health priority?

Following the European Commission’s decision to disband the Expert Group on Dementia, we speak to Alzheimer Europe to hear their case for a co-ordinated...
Mucopolysaccharide storage diseases and puberty and adolescence

Mucopolysaccharide storage diseases and puberty and adolescence

The Medical University of Vienna’s Susanne Gerit Kircher reflects on the medical progress that has allowed people affected by mucopolysaccharide storage diseases to start...
Prudenta: an electronic solution for local literature monitoring in pharmacovigilance

Prudenta: an electronic solution for local literature monitoring in pharmacovigilance

Dr Polina Dombure, the managing director of Inpharmatis, introduces Prudenta, an innovative pharmacovigilance solution set to transform local literature monitoring. The costly, time-consuming and error-prone...
Neurosteer: introducing a novel brain activity monitor

Neurosteer: introducing a novel brain activity monitor

Neurosteer has developed a three-electrode neurological monitor that provides multiple brain activity biomarkers. Neurosteer has the mission to improve the quality of brain disorder care...
Health Europa Quarterly Issue 07

Health Europa Quarterly Issue 07

Exploring the rapidly changing environment of healthcare, Health Europa Quarterly issue 07 delves into environmental and climate-related harm and discusses the evolution of medical...
Assessing the environmental risk of pharmaceuticals

Assessing the environmental risk of pharmaceuticals

AstraZeneca’s Jason Snape, outlined his company’s approach to the environmental risk assessment of human medicinal products and what more needs to be in place...
The Fool’s Tower: Europe’s oldest building that accommodated mental patients

The Fool’s Tower: Europe’s oldest accommodation for mental patients

Health Europa explores with those involved in managing and expanding the then-hospital for mental patients, Vienna’s Narrenturm (Fool’s Tower). In September, Health Europa travelled to...
Challenges and opportunities in cancer drug development

Challenges and opportunities in cancer drug development

Managing director Professor Heinz Zwierzina of the Cancer Drug Development Forum talks Health Europa through the challenges in the search for new cancer drugs. The...
Sleep and pain relief on demand, from Sana Health

Sleep and pain relief on demand, from Sana Health

Sana Health introduces its neuromodulation device, which is easing pain, improving sleep, and could save many lives. IN 1992, the founder of Sana Health, Richard...
Medical technologies in the fight against antimicrobial resistance

Medical technologies in the fight against antimicrobial resistance

Medical technologies are in a unique position to address several of the key challenges we face when thinking about antimicrobial resistance, as MedTech Europe...
It’s time for the UK to rethink its approach to medical cannabis

It’s time for the UK to rethink its approach to medical cannabis

Producing and exporting the most amount of medical cannabis in the world - why is medical cannabis still being denied to patients in the...
In focus: rheumatoid arthritis medication and treatments

In focus: rheumatoid arthritis medication and treatments

What do we know about rheumatoid arthritis medication? What are the recommended first-line treatment for this debilitating disease? Read more as Health Europa investigates. Rheumatoid arthritis...
The Swiss perspective on mucopolysaccharide disease

The Swiss perspective on mucopolysaccharide disease

Dr Fredi Wiesbauer, vice president of the Swiss Mucopolysaccharide disease (MPS) Society met with Health Europa and explored the Swiss experience of hosting such...
Towards personalised medicine: Artificial Intelligence in cancer

Towards personalised medicine: Artificial Intelligence in cancer

Dr Andrea Sottoriva introduces REVOLVER and considers the wider application of Artificial Intelligence in cancer research and care. Developed by scientists at The Institute of...
Horizon 2020 and the Israeli Ministry of Health

Horizon 2020 and the Israeli Ministry of Health

Israel has enjoyed enormous success in EU framework programmes since first becoming associated in 1996. Here, Health Europa highlights the involvement of the Israeli...
HepatoPredict: stratifying liver cancer patients for transplantation

HepatoPredict: stratifying liver cancer patients for transplantation

The HepatoPredict - a powerful predictive tool to accurately select hepatocellular carcinoma patients for successful liver transplantation. Dr José Pereira Leal, the founder and executive...
Pharmacovigilance in the EU: a closer look at EudraVigilance

Pharmacovigilance in the EU: a closer look at EudraVigilance

Health Europa highlights the role of EudraVigilance in the pharmacovigilance activities of the EMA, from the launch of the revamped system in 2017 to...
Learning from Nature understanding sustainable antibiotic use

Learning from Nature: understanding sustainable antibiotic use

There is a pressing need to better understand sustainable antibiotic use and the evolution of resistance in infectious diseases. The evolution of antibiotic-resistant pathogens poses...
New targeted methotrexate underway for rheumatoid arthritis

New targeted methotrexate underway for rheumatoid arthritis

ROS Therapeutics APS has developed a targeted methotrexate prodrug to mitigate the side effects experienced by many rheumatoid arthritis patients. Danish start-up company ROS Therapeutics...
The MedTech SuperConnector: accelerating commercialisation in the UK health sector

MedTech SuperConnector: accelerating commercialisation in UK health sector

Health Europa introduces the MedTech SuperConnector and explores how it will help to translate promising research into commercialisation in the UK. In April, Research England...

Pin It on Pinterest